Comparison of Saypha and Radiesse Dermal Fillers

The wide range of products available for aesthetic treatments can make dermal filler selection challenging, even for experienced physicians, dermatologists, and plastic surgeons. As new formulations enter the market, differences between products may involve their chemical composition, rheological characteristics, indications, injection depth, and intended aesthetic outcomes.

To help clinicians evaluate the available options, this dermal filler comparison examines products from Saypha and Radiesse. The discussion covers their principal materials, mechanisms of action, typical treatment applications, and practical differences that may influence product selection.

Rather than considering one filler universally superior to another, clinicians should assess each formulation according to the patient’s anatomy, treatment objective, medical history, product-specific instructions for use, and applicable regulatory requirements.

Key Takeaways

• Saypha is a portfolio of hyaluronic acid (HA) dermal fillers, while Radiesse is primarily a calcium hydroxylapatite (CaHA)-based injectable implant.
• HA fillers provide volumization and tissue support and can generally be degraded with hyaluronidase when clinically appropriate; CaHA has different physical and biological characteristics and is not reversed with hyaluronidase in the same manner.
• Product characteristics, approved indications, injection planes, and available clinical evidence vary among individual formulations.
• Filler selection should be based on anatomy, treatment goals, product-specific evidence, and the clinician’s training rather than brand preference alone.

Clinicians looking to buy Radiesse online should obtain products through appropriate professional channels and verify the formulation, intended indication, regulatory status, and applicable prescribing or purchasing requirements in their jurisdiction.

About: Doctor Medica is your trusted supplier of top-quality dermal fillers, viscosupplements, and a range of medical and aesthetic products for your practice. We offer authentic products from leading brands at the lowest prices. 

Saypha Dermal Fillers Overview

This brand is a portfolio of hyaluronic acid dermal fillers associated with Croma-Pharma. The portfolio developed from the company’s earlier Princess-branded filler range, although product names, formulations, indications, and market availability can vary by country.

Saypha products are based on hyaluronic acid, a naturally occurring glycosaminoglycan involved in tissue hydration and extracellular matrix structure. In injectable fillers, cross-linking modifies the physical properties and persistence of HA gels, allowing different formulations to be designed for particular aesthetic applications.

Saypha products are not a single uniform filler. Their concentrations, cross-linking characteristics, rheological properties, lidocaine content, and intended applications can differ. Consequently, clinicians should consult the current product-specific instructions for use rather than applying the characteristics of one Saypha formulation to the entire portfolio.

Clinical evidence for the broader Saypha/Princess HA portfolio includes prospective studies evaluating facial applications and a postmarket randomized clinical study of Saypha LIPS Lidocaine for lip augmentation.

Specialized Fillers By Saypha And Their Key Characteristics

The Saypha portfolio includes formulations intended for different facial treatment objectives. Because product availability and approved indications vary geographically, clinicians should verify the current local documentation before treatment.

Like other injectable HA fillers, Saypha products can produce temporary injection-site reactions such as swelling, redness, tenderness, bruising, or discomfort. These effects are generally localized and transient, but HA fillers can also cause less common delayed inflammatory reactions and rare but serious vascular complications.

The fact that HA occurs naturally in human tissues does not eliminate the possibility of adverse events. Appropriate patient selection, anatomical knowledge, sterile technique, and management of complications remain essential.

SAYPHA Filler and SAYPHA Filler With Lidocaine

Depending on the specific market and product documentation, it may be indicated for correction of facial volume deficiencies, wrinkles, folds, or other soft-tissue contour irregularities.

Potential applications described for appropriate Saypha formulations may include:

1. Correction of moderate-to-severe facial wrinkles and folds
2. Restoration of localized facial volume deficiencies
3. Correction of selected contour irregularities
4. Lip augmentation where the specific product is indicated
5. Treatment of other approved indications according to the local instructions for use

The duration of correction varies with the formulation, injection technique, anatomical site, and individual patient factors, so a universal nine-month duration should not be assumed.

SAYPHA VOLUME PLUS With Lidocaine 

A higher-density HA formulation can provide structural support for areas requiring greater projection or volume restoration. Depending on local authorization, potential applications may include:

1. Correction of pronounced facial folds
2. Facial contouring
3. Restoration of midfacial volume
4. Correction of selected depressions
5. Areas requiring a more cohesive volumizing gel

Lidocaine is included to improve procedural comfort, although it does not make injection completely painless.

SAYPHA VOLUME and SAYPHA VOLUME With Lidocaine

Depending on the approved indication, it may be considered for:

1. Cheek and chin contouring
2. Correction of selected facial hollows
3. Moderate-to-deep facial folds
4. Restoration of localized facial volume
5. Other indications specified in the product documentation

The product’s rheological characteristics and injection depth should be evaluated before use rather than inferred solely from the product name.

SAYPHA RICH

SAYPHA RICH is a less cross-linked HA formulation intended for more superficial applications and skin-quality-oriented treatment objectives.

Depending on the specific indication and market authorization, it may be considered for:

1. Superficial fine lines
2. Areas requiring hydration-focused treatment
3. Selected superficial perioral lines
4. Improvement of the appearance of skin texture and hydration

Treatment schedules and persistence should follow the manufacturer’s instructions rather than assuming a universal six-month duration.

Radiesse Dermal Fillers Overview

Radiesse is a calcium hydroxylapatite (CaHA)-based injectable implant associated with Merz Aesthetics. Unlike HA fillers, CaHA consists of calcium hydroxylapatite microspheres suspended in a gel carrier.

The formulation provides an initial volumizing or contouring effect while the CaHA component gradually undergoes resorption. Research has also investigated CaHA’s ability to stimulate tissue remodeling and collagen production, although the magnitude and clinical relevance of these effects depend on formulation, dilution, treatment area, and technique.

Clinical evidence supports CaHA for selected facial aesthetic indications, and studies have also investigated its use in areas such as the backs of the hands and décolletage. However, the indication and regulatory authorization should always be verified for the particular Radiesse formulation and country.

Unlike HA fillers, CaHA cannot be enzymatically dissolved with hyaluronidase. This distinction is clinically important when considering product selection and complication management.

Specialized Fillers By Radiesse And Their Key Characteristics

Radiesse formulations are based on calcium hydroxylapatite suspended in a carboxymethylcellulose-based carrier, with certain versions also containing lidocaine.

The adverse-event profile can include temporary swelling, redness, bruising, tenderness, and discomfort. Nodules and other localized complications can also occur, particularly when product placement, patient selection, or treatment technique is inappropriate. A systematic review of CaHA literature identified nodules as the most frequently reported adverse event among the complications evaluated.

Clinicians should also recognize that dermal filler injections carry a risk of vascular occlusion and, in rare circumstances, tissue ischemia or visual complications. These risks make anatomical knowledge and appropriate complication-management protocols essential.

Specific injection areas and techniques should follow the current manufacturer instructions and applicable clinical guidance rather than a generalized rule for every Radiesse product.

RADIESSE 0.8 ml and 1.5 ml

Depending on the applicable authorization, it may be used for selected facial wrinkles, folds, volume deficiencies, contouring, or other approved indications.

Potential applications can include:

1. Correction of moderate-to-severe facial wrinkles and folds
2. Restoration of selected areas of facial volume
3. Facial contouring
4. Treatment of selected age-related volume loss
5. Selected hand-rejuvenation applications where authorized

Clinical studies have demonstrated sustained improvement following Radiesse treatment for certain facial indications, although the degree and duration of improvement vary among patients.

RADIESSE (+) 0.8 ml and 1.5 ml with Lidocaine

This formulation contains calcium hydroxylapatite suspended in the gel carrier with lidocaine. Depending on local authorization, potential applications may include:

1. Correction of moderate-to-severe facial wrinkles and folds
2. Selected facial contouring procedures
3. Restoration of facial volume
4. Treatment of specific soft-tissue deficiencies
5. Other indications included in the current product labeling

The inclusion of lidocaine may improve procedural comfort but does not eliminate injection-related discomfort.

Comparison of Saypha and Radiesse Filler Lines

Both reviewed filler brands are good in their own way. As a responsible dermal filler supplier, we will outline particularities to consider.

Similarities Shared By Fillers

1. Both brands are made of substances naturally occurring in the human body and are biocompatible and biodegradable.
2. Both brands can be safely injected into facial areas and the décolletage to fill wrinkles, smooth skin unevenness, fill cavities and indentations, contour, and gently sculpt the face.
3. They can have lidocaine in their formula for a better injection experience.

Differences Among Fillers 

Although both are injectable aesthetic products, Saypha and Radiesse differ substantially in their active materials and biological behavior.

1. Saypha filler can be injected into the lips and glabella area, while Radiesse is not recommended for it yet can be injected into the backs of the hands
2. Saypha line is made of hyaluronic acid, and Radiesse – of calcium microspheres suspended in the liquid
3. Saypha products have various degrees of density and viscosity
4. Saypha fillers last up to 9 months, while Radiesse lasts up to 18 months
5. Radiesse fillers start the production of collagen in the body, while Saypha fillers do not.

Efficacy and Safety Overview

Clinical evidence supports the use of both HA and CaHA fillers for selected aesthetic indications, but results from one product should not automatically be extrapolated to another.

A clinical study of the Princess HA filler, the predecessor portfolio associated with Saypha, reported improvements in facial lipoatrophy, morphological asymmetry, and selected scars. More recent postmarket evidence specifically evaluating Saypha LIPS Lidocaine has also assessed efficacy and short- and long-term safety in lip augmentation.

For Radiesse, clinical studies and systematic reviews support its use for selected facial applications, while also documenting adverse events that clinicians should understand before treatment.

A comparison such as Radiesse vs Sculptra also illustrates why filler categories should not be treated as interchangeable: different biostimulatory materials have distinct compositions, handling characteristics, evidence bases, and indications.

Tips on Choosing the Appropriate Dermal Filler For The Task

Product selection should begin with the patient’s anatomy and the clinical objective rather than the brand name. Clinicians should consider whether the primary goal is superficial correction, soft-tissue volumization, structural contouring, or a broader skin-quality treatment objective.

Saypha HA fillers may be appropriate when a clinician requires an HA-based product with specific rheological characteristics or when reversibility with hyaluronidase is an important consideration.

Radiesse may be considered for selected indications where CaHA’s volumizing and biostimulatory characteristics are appropriate. Evidence from controlled clinical studies and systematic reviews supports CaHA for selected facial and hand applications, although the evidence is heterogeneous across treatment areas.

The final decision should account for the patient’s anatomy, treatment history, contraindications, expectations, and the specific product’s regulatory status and instructions for use.

Treatment And Post-Treatment Recommendations

When selecting between these filler categories, clinicians should follow product-specific instructions and established injection protocols. Preparation, injection depth, cannula or needle selection, and post-treatment management should not be assumed to be identical across products.

Preparation and Injection Technique for Saypha and Radiesse 

The preparation step is similar for both fillers: 

1. Disinfect the treatment area
2. Assemble the syringe and the needle
3. Push out all the air from the syringeInject
4. Gently massage or smooth the filler under the skin to distribute it evenly, without lumps
5. If the gel remains in the syringe, discard it.

The injection steps differ because of the properties and consistency of fillers. 

Radiesse is injected into deep layers of skin or muscle, with the needle at a 30-degree angle to the skin surface. The filler is deposited in parallel lines in tissues to avoid clotting and lumping. 

Thin Saypha fillers can be injected superficially in directions required by the desired results. 

Dense Saypha fillers are deposited in the mid and deep layers of tissue. If filling a cavity, inject the gel until the desired result is achieved. For smoothing lines and small indentations, inject the gel in tiny portions to control the outcome. 

When used to augment lips, the filler must be injected according to the lip anatomy and desired effect (cherry lips, plumping, tenting, contouring, etc.).

Aftercare For Better Results And Lower Risks Of Complications

After injections, patients should avoid hot environments, baths, and beaches for 24 hours. It is advisable to sleep on one’s back and skip facial massage and intensive physical training for the first 24 hours to avoid misplacement or deformation of an implant. 

Downtime is usually not required; an ice pack can be used to reduce discomfort immediately after the injection.

Results and Patient Satisfaction delivered by Saypha and Radiesse

All fillers as cosmetic products were initially designed to fill wrinkles and unwanted cavities and to plump and refill dehydrated skin. Another goal was to improve the shape of cheeks, chin, cheekbones, and lips, thus making people look younger, fresher, and more beautiful. 

Both Saypha and Radiesse are expected to provide this effect of augmentation and rejuvenation of the face and décolletage, making contours more defined, skin plumper, and lips juicier. In addition, Radiesse should help fill cavities on the backs of the hands that appear with age.

Comparison Of Actual Outcomes, According To Patients

Patient outcomes depend on more than filler selection. Treatment planning, anatomy, injection technique, baseline tissue characteristics, product characteristics, and individual healing responses all contribute to the final result.

Saypha may be selected when an HA formulation is appropriate for a particular facial indication, including selected volumization or lip applications. Radiesse may be considered when a CaHA-based product is appropriate for specific volumizing, contouring, or biostimulatory objectives.

Consequently, Saypha and Radiesse should be viewed as different categories of injectable materials rather than interchangeable products. Comparing their composition, intended indications, evidence, and reversibility provides a more clinically meaningful basis for selection than comparing brand names alone.

Conclusion

Saypha and Radiesse represent two distinct approaches to injectable soft-tissue correction. Saypha products use hyaluronic acid formulations with varying characteristics, while Radiesse uses calcium hydroxylapatite and can provide both volumizing and biostimulatory effects.

The appropriate choice depends on the treatment indication, anatomy, product-specific evidence, regulatory status, clinician expertise, and patient expectations. Rather than assuming one filler is universally better, practitioners should evaluate the individual formulation and use it according to its current labeling and professional clinical guidance.

For licensed medical professionals, careful product selection and appropriate injection technique remain central to achieving predictable aesthetic outcomes while minimizing preventable complications.

Citations

[1] Kopera, Daisy, et al. “Treatment of Facial Lipoatrophy, Morphological Asymmetry, or Debilitating Scars With the Hyaluronic Acid Dermal Filler Princess® FILLER.” Taylor & Francis, Nov. 2018, www.tandfonline.com/doi/full/10.2147/CCID.S181964.

[2] Kadouch, J. A. “Calcium Hydroxylapatite: A Review on Safety and Complications.” Journal of Cosmetic Dermatology, vol. 16, no. 2, Mar. 2017, pp. 152–61. https://doi.org/10.1111/jocd.12326.

[3] Bass, L. S., et al. “Calcium Hydroxylapatite (Radiesse) for Treatment of Nasolabial Folds: Long-Term Safety and Efficacy Results.” Aesthetic Surgery Journal, vol. 30, no. 2, Mar. 2010, pp. 235–38. https://doi.org/10.1177/1090820×10366549.